Pranav Shah

Pfizer (United States)

Papers

1

Total Citations

59

H-Index

1

About

Pranav Shah is a leading researcher in drug metabolism and pharmacokinetics (DMPK), with a focus on advancing high-throughput screening technologies for pharmaceutical development. His most-cited work, "An Automated High-Throughput Metabolic Stability Assay Using an Integrated High-Resolution Accurate Mass Method and Automated Data Analysis Software" (2016), has garnered 59 citations, underscoring its impact on streamlining early-stage drug discovery. Shah's major contributions lie in developing integrated, automated platforms that combine high-resolution accurate mass spectrometry with sophisticated data analysis tools, enabling rapid and reliable assessment of metabolic stability—a critical parameter in drug candidate selection. By reducing manual intervention and enhancing throughput, his methods have accelerated the identification of promising compounds, saving time and resources in preclinical pipelines. This work exemplifies his commitment to bridging analytical chemistry and computational efficiency, offering practical solutions for the pharmaceutical industry. Shah’s research is particularly valuable for students and researchers seeking to understand how automation and high-resolution mass spectrometry can transform DMPK assays, making them more robust and scalable. His achievements highlight a career dedicated to innovation in drug metabolism science, with lasting implications for drug development efficiency.

Research Focus

Key Achievements

1
H-Index
1
Papers
59
Total Citations
59
Avg Citations/Paper
🏆 Most Cited Paper
An Automated High-Throughput Metabolic Stability Assay Using an Integrated High-Resolution Accurate Mass Method and Automated Data Analysis Software
59 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Pfizer (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago